Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDRT15 pseudogene 4 (CDRT15P4) is a human pseudogene located at chromosome 2 (hg38: chr2:131766187-131767221). It is classified as a pseudogene based on annotation datasets; no evidence exists for it encoding a functional protein, participating in biological regulatory processes, or being involved in molecular pathways associated with disease. There is no literature linking CDRT15P4 to therapeutic intervention, disease modulation, or utility as a biomarker. It should not be regarded as a druggable or actionable target. Essential context: - The nomenclature and context “CMT1A duplicated region transcript” refers to its positional mapping and sequence homology in genomic studies, particularly in the Charcot-Marie-Tooth disease type 1A (CMT1A) duplication region. - CDRT15 itself is a small protein-coding gene involved in genomic studies of the CMT1A/HNPP region, but CDRT15P4 is a specifically annotated pseudogene, not a protein-coding or disease-relevant entity. - No links to biological activity, disease roles (including CMT1A), or any interacting drugs or mechanisms appear in the biomedical literature or gene annotation datasets consulted. Summary of findings: - CDRT15P4 is solely a pseudogene and does not encode a functional protein. - No evidence for utility as a therapeutic target, biomarker, or disease effector. - The gene entry is accurate, but not relevant for therapeutic or research targeting based on current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDRT15 pseudogene 4 (CDRT15P4).